112 related articles for article (PubMed ID: 8121308)
1. MDL 29311, an analog of probucol, decreases triglycerides in rats by increasing hepatic clearance of very-low-density lipoprotein.
Sheetz MJ; Barnhart RL; Jackson RL; Robinson KM
Metabolism; 1994 Feb; 43(2):233-40. PubMed ID: 8121308
[TBL] [Abstract][Full Text] [Related]
2. MDL 29311, a phenolic antioxidant, interferes with the interaction of apoC with VLDL: a possible explanation for its triglyceride-lowering effect.
Sheetz MJ
J Lipid Res; 1995 Dec; 36(12):2609-21. PubMed ID: 8847487
[TBL] [Abstract][Full Text] [Related]
3. Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat.
Strandberg T; Kuusi T; Tilvis R; Miettinen TA
Atherosclerosis; 1981; 40(3-4):193-201. PubMed ID: 7332600
[TBL] [Abstract][Full Text] [Related]
4. MDL 29311. Antioxidant with marked lipid- and glucose-lowering activity in diabetic rats and mice.
Johnson MB; Heineke EW; Rhinehart BL; Sheetz MJ; Barnhart RL; Robinson KM
Diabetes; 1993 Aug; 42(8):1179-86. PubMed ID: 8325450
[TBL] [Abstract][Full Text] [Related]
5. The effects of probucol on the levels, structure, composition and metabolism of plasma lipoprotein in rats.
Eisenberg S
Biochim Biophys Acta; 1993 Mar; 1167(1):79-84. PubMed ID: 8461336
[TBL] [Abstract][Full Text] [Related]
6. Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase.
Homma Y; Moriguchi EH; Sakane H; Ozawa H; Nakamura H; Goto Y
Atherosclerosis; 1991 Jun; 88(2-3):175-81. PubMed ID: 1892484
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
[TBL] [Abstract][Full Text] [Related]
8. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates.
Lefebvre AM; Peinado-Onsurbe J; Leitersdorf I; Briggs MR; Paterniti JR; Fruchart JC; Fievet C; Auwerx J; Staels B
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1756-64. PubMed ID: 9327774
[TBL] [Abstract][Full Text] [Related]
9. Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats.
Mamo JC; Elsegood CL; Umeda Y; Hirano T; Redgrave TG
Arterioscler Thromb; 1993 Feb; 13(2):231-9. PubMed ID: 8381300
[TBL] [Abstract][Full Text] [Related]
10. Effect of probucol on triglyceride turnover in streptozotocin-diabetic rats.
Yoshino G; Matsushita M; Maeda E; Nagata K; Morita M; Matsuba K; Tani T; Horinuki R; Kimura Y; Kazumi T
Atherosclerosis; 1991 May; 88(1):69-75. PubMed ID: 1878011
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term administration of probucol on triglyceride turnover in rats.
Yoshino G; Matsushita M; Maeda E; Nagata K; Naka Y; Murata Y; Hirano T; Kazumi T
Coron Artery Dis; 1994 Jan; 5(1):67-72. PubMed ID: 8136934
[TBL] [Abstract][Full Text] [Related]
12. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
13. Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver.
Salam WH; Wilcox HG; Heimberg M
Biochem J; 1988 May; 251(3):809-16. PubMed ID: 3166373
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
15. The effects of probucol on lipoprotein metabolism in the rat.
Staels B; van Tol A; Jansen H; Auwerx J
Biochim Biophys Acta; 1991 Aug; 1085(1):131-5. PubMed ID: 1892873
[TBL] [Abstract][Full Text] [Related]
16. Catabolism of very low density lipoproteins in experimental nephrosis.
Garber DW; Gottlieb BA; Marsh JB; Sparks CE
J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
[TBL] [Abstract][Full Text] [Related]
17. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
[TBL] [Abstract][Full Text] [Related]
18. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.
St-Amand J; Moorjanit S; Lupien PJ; Prud'homme D; Després JP
Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500
[TBL] [Abstract][Full Text] [Related]
19. The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia.
Dachet C; Jacotot B; Buxtorf JC
Atherosclerosis; 1985 Dec; 58(1-3):261-8. PubMed ID: 4091882
[TBL] [Abstract][Full Text] [Related]
20. Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitro.
Trezzi E; Roma P; Bernini F; Fumagalli R; Catapano AL
Atherosclerosis; 1984 Sep; 52(3):309-16. PubMed ID: 6093829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
